Clinical data on track for Q4 2025 from Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLC; Expansion of investigator sponsored Phase 0/1 trial into newly di ...

The Motley Fool. DATE Wednesday, May 21, 2025, at 8:30 a.m. EDT Read More: Earn up to $845 cash back this year just by ...

Clinical data on track for Q4 2025 from Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLCExpansion of investigator sponsored Phase 0/1 trial into newly diagnosed glioblastoma pa ...

CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading live biotherapeutics company, today reported first quarter 2025 financial ...

With a strong balance sheet ... consistent safety of the 25mg dose and suggests that higher doses of agomelatine do not result in greater efficacy. The Company believes these data support ...

First of several clinical updates through mid-2026 accepted for presentation at the 2025 American Society of Clinical Oncology Annual Meeting, with recruitment progressing for all three of our clinica ...

The U.S. Cybersecurity & Infrastructure Security Agency (CISA) released guidance calling on legacy Oracle Health/Cerner users to confirm the security of their credential material ... safety, and what ...

If there’s one thing that the history of the Jurassic Park and Jurassic World franchise has taught us, it’s that life will ...

Frank DeStefano, MD, MPH, was there when the CDC's Vaccine Safety Datalink (VSD) first came online in 1990, when the agency ...

As the apparent stability of past decades gives way to a more unpredictable behaviour, investors are attempting to run for ...

The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of American City Business Journals.